MedCity News September 24, 2021
Elligo Health Research uses EHR data, technology and services to expand patient access to clinical trials. It will use the new funds to further invest in its technology platform and purchase research practice management company ClinEdge.
Elligo Health Research, a clinical research and technology company, has raised $135 million in a new funding round led by Morgan Stanley Expansion Capital and Ally Bridge Group.
Existing investors, including Cerner, Norwest Venture Partners, Hatteras Venture Partners and Syneos Health, also participated in the Series E financing round.
Founded in 2016, Austin, Texas-based Elligo Health Research aims to expand patient access to clinical trials. It uses EHR data, technology and services to support all types of clinical trial designs — traditional, hybrid and...
Today's Sponsors
Today's Sponsor